Norditropin 48 IU Novo Nordisk | TPT-0165
The article is for informational purposes and is compiled according to the official instructions
Information for those wishing to purchase Norditropin Novo Nordisk in England
Norditropin Novo Nordisk is popular due to the fact that its action is ideal for building muscle mass that has a relief appearance, which is highly appreciated by athletes. You can buy Norditropin 48 IU Novo Nordisk with delivery at the best price in England simply by placing an online order on the website of our online shop.
Norditropin 48 IU Novo Nordisk is a preparation of somatotropic hormone. It stimulates skeletal and somatic growth and has a pronounced effect on metabolic processes. Norditropin 48 IU Novo Nordisk, replacing the deficiency of endogenous growth hormone, contribute to the normalisation of body structure by increasing muscle mass and decreasing fat mass.
Application of Norditropin 48 IU Novo Nordisk
Most of the effects of Norditropin 48 IU are produced by insulin-like growth factor I (IRF-I), which is produced in all body cells (mainly in liver cells). More than 90% of IRF-I is bound to proteins (IRFSB), of which IRFSB-3 is the most important.
Norditropin enhances bone remodelling, which is manifested by an increase in plasma activity of biochemical markers of bone tissue. In adults, due to more pronounced bone resorption, bone mass decreases in the first months of treatment, but as treatment continues, bone mass increases.
Side effects of Norditropin 48 IU
Possible: increased intracranial pressure (headache, nausea, vomiting, visual disturbances), decreased thyroid function, hyperglycaemia, leukaemia, epiphysiolysis of the femoral head, fluid retention with peripheral oedema, arthralgia, myalgia, tunnel syndrome. Symptoms are usually transient, dose-dependent and may require dose reduction.
- Allergic reactions: skin rash, itching.
- Rare: formation of antibodies to the drug with reduced efficacy.
Local reactions: Hyperemia, swelling, pain, itching, lipoatrophy at the injection site.
Contraindications to the drug application
- malignant neoplasms;
- active brain tumours;
- Emergency conditions (including conditions following cardiac, abdominal or acute respiratory failure);
- Breast-feeding (do not breast-feed for the treatment period);
- Hypersensitivity to the components of the drug.
- Caution should be exercised in the presence of diabetes mellitus, intracranial hypertension, hypothyroidism.
|Active ingredient, IU||48|